Clinical Trial Update: Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating esmolol for sepsis management, focusing on immunomodulatory effects and patient outcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Esmolol (esmolol)

Snippet

Sponsor: Lin Chen | Conditions: Sepsis, Lymphocyte Disorder T | Phase 2 | Status: COMPLETED